Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Candida Vitale

A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia

scientific article

Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia

scientific article published on 29 February 2016

Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives

scientific article published on 01 June 2019

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.

scientific article published on 26 May 2015

Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib

scientific article published on 24 March 2016

Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia

scientific article published on 26 May 2015

CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results

scientific article published on 11 June 2019

CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia

scientific article published on 30 March 2018

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

scientific article published on 01 November 2021

Chronic lymphocytic leukemia therapy: new targeted therapies on the way

scientific article published on 17 March 2016

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

scientific article

Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method.

scientific article

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.

scientific article published on 29 August 2012

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12

scientific article published on 26 June 2019

External validation of the accuracy of 'CLLflow score'

scientific article published on 14 September 2018

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia

scientific article

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

scientific article published on 04 March 2011

Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

scientific article published on 23 February 2016

Magic pills: new oral drugs to treat chronic lymphocytic leukemia.

scientific article

Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics

scientific article published on 05 January 2016

Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies

scientific article published on 18 April 2019

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy

scientific article published on 03 July 2020

Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.

scientific article published on 24 June 2017

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies

scientific article published on 21 December 2017

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.

scientific article published on 27 May 2015

The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia

scientific article published on 23 July 2020

The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting.

scientific article published on 3 July 2014

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab

scientific article published on 16 September 2020

Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.

scientific article published on 17 May 2011